Robert Besthof - Interim CEO at NRX Pharmaceuticals, Inc.

Issuer-level insider activity

Role
Interim CEO
Issuer ticker
NRXP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Robert Besthof since 24 Aug 2025

Reported holdings for Robert Besthof in NRX Pharmaceuticals, Inc.

Form 4 holding Interim CEO

NRX Pharmaceuticals, Inc.

Security class
Employee Stock Option
Shares / value
347,200
Estimated value
Report date
08 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Robert Besthof in NRX Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .